A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...
Novo Nordisk is introducing a first-of-its-kind weekly dose for Type 2 diabetes. It can offer greater convenience and less pain, but there are hypoglycemia risks.
People with type I diabetes have to inject themselves multiple times a day with manufactured insulin to maintain healthy levels of the hormone, as their bodies do not naturally produce enough. The ...
The trial specifically addressed patients with uncontrolled hypertension despite ongoing therapy. High blood pressure affects over a billion people globally, but traditional daily oral regimens ...
Results from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that giving people with high blood pressure an injection every six months can lead ...
A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...
NEW YORK, Aug 17 (Reuters) - Blood injections, especially of platelet-rich blood, into the affected area help relieve the pain associated with "tennis elbow" where other treatment methods have failed, ...
2 Department of General Practice and Primary Health Care, School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, New Zealand 3 School of Sport and Exercise, ...
One startup insists that young blood is the key to reversing the aging process. Pictured: A nurse takes blood of a donor during an EFS (Etablissement Francais du Sang) blood donation campaign on ...
A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results